Novartis files infringement claim against Ranbaxy over Gleevec patent
Novartis Pharmaceuticals sued Ranbaxy, Inc. and Ranbaxy Laboratories on Dec. 29 over allegations of patent infringement. The suit followed the defendants’ submission of an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) to pursue the creation of a generic form of the Gleevec drug.
Clarizen awarded patent for its email-based workflow system
The patent relates to the company’s InterAct email engine which lets users trigger specific project-related actions like approval processes, generating reports, creating new projects and other workflows through their email.
Dahua Technology announces strategic agreement with Exar to license HDCVI technology
Dahua Technology, a world-leading manufacturer and supplier of video surveillance products headquartered in Hangzhou, China announces the signing of a strategic agreement with Exar to license High Definition Composite Video Interface (HDCVI) technology. Under the terms of the new agreement, Exar is licensed to design, manufacture and sell high-definition analog video solutions utilizing HDCVI technology.
Spider9 to license intellectual property to SAMSUNG electronics
Spider9, an advanced energy storage and controls company, announced today a technology licensing agreement with Korean industrial conglomerate Samsung Electronics (“Samsung”) for use of the company’s proprietary Energy Operating System (OSE) technology. The agreement opens the door for the first application of OSE technology outside of the stationary energy storage market.
ISSI to License Spansion hyperflash™ Memory and hyperbus™ Interface
Integrated Silicon Solution, Inc., a leader in advanced memory solutions, and Spansion, a global leader in embedded systems solutions, today announced a licensing agreement that provides ISSI access to Spansion’s hyperflash™ memory and hyperbus™ technology portfolio, as well as access to mirrorbit™ technology in Spansion’s foundries.
Helsinn and Pharmacosmos Enter into an Exclusive License Agreement
Helsinn Group and Pharmacosmos A/S today jointly announce that they have entered into an agreement for the exclusive US commercialization rights to Monofer®, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia.
Acura pharmaceuticals partners with Egalet
Acura and Egalet will form a joint steering committee to coordinate commercialization strategies and the development of product line extensions. Egalet will be responsible for all commercial, regulatory and manufacturing activities. The parties are working to transition the product to Egalet for commercial launch in the U.S. as soon as commercially practical.
One of Apple’s Technical Touch ID Patents comes to Light
US Patent & Trademark Office published a patent application from Apple that reveals certain aspects of the technology behind fingerprint sensors that measure fingerprint patterning using electric field sensing. Apple notes that when the voltages on the finger are too high, as when using Touch ID, certain persons with very sensitive fingers may feel that voltage in form of a slight tingling.
National research apply for a patent on the treatment of cancer gold
Dr. Ahmed Abdoun, a professor of veterinary Division National Research Center, and Chairman of the private research group said the experiences of cancer animal home using gold particles treatment
Orbite Receives Notice of Allowance for Patent Related to Red Mud Treatment
Orbite Aluminae Inc. announced that it had received a notice of allowance from the Canadian Intellectual Property Office for its patent application pertaining to processes for treating red mud.
Read More
RestorGenex receives European patent for skin treatment RES-529
RestorGenex Corp. announced that the European Patent Office has issued the company a patent titled, “Compositions and Methods to Treat Skin Diseases Characterized by Cellular Proliferation and Angiogenesis”.
Patent Trial and Appeal Board Denies IPR Petition Aimed at ParkerVision ‘342 Patent
ParkerVision, Inc., a developer and marketer of semiconductor technology solutions for wireless applications, today announced that on January 8, 2015, the Patent Trial and Appeal Board (“PTAB”) denied institution of trial of all challenged claims for Inter Partes review (“IPR”) of ParkerVision patent 7,496,342 (“the ‘342 patent”)
US to probe Sony, others over headset patent infringement
The U.S. International Trade Commission said Thursday it will investigate 13 companies including Sony Corp. of Japan and its affiliates over their possible infringement of patents of a U.S. firm for wireless audio devices including headsets.
Read More
UBIC Obtains New Japanese Patent for Technology Related to Email Auditing System
UBIC, Inc. a leading provider of international litigation support and big-data analysis services, today announced that the Japan Patent Office has recently issued a Notification of Decision of Grant to the Company for a patent application related to “Email Auditing System”.
Johnson & Johnson Seeks Patent on Electronic Contact Lenses
Recent Johnson & Johnson patent applications have been focused on the development of electronic components for contact lenses. Patent applications published by the U.S. Patent and Trademark Office covered today include lenses with energized elements for cosmetic enhancements or the prevention of counterfeit products.
Patent Brief: Apple Adds Multimedia to Future Digital Newspaper
US Patent & Trademark Office published a patent application from Apple that reveals a little more of their work on their recently granted patent regarding a future digital newspaper or periodical. Apple wants to add multimedia.
Kyle bass’s assault on pharma patents
Kyle Bass, founder of Hayman Capital, in a presentation on January 7th in Oslo, Norway announced that he will be challenging big pharma’s patent assets. Mr. Bass said he will be targeting 15 firms with a combined market value of $450 billion
